Wockhardt receives USFDA approval for Oxacillin injection

Wockhardt has received final USFDA approval for its generic Oxacillin injection used for the treatment of bacterial infections. The drug will be made available in the strengths of 1 gm and 2 gm. The company is expected to launch this product in the United States soon. The product is being manufactured at a contract manufacturing facility, based near Milan, Italy. Oxacillin, an antibiotic, is used to treat many infections caused by penicillin-resistant Staphylococcal and other bacterias, including urinary tract infections, respiratory tract issues, septicemia, wounds and bacterial meningitis.

Company Profile : Wockhardt Ltd

Be the first to comment

Leave a Reply

Your email address will not be published.